CD8 alpha 抗体
Quick Overview for CD8 alpha 抗体 (ABIN135118)
抗原
See all CD8 alpha (CD8A) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Mouse CD8α, Mr 32-34 kDa
-
产品特性
- Rat Anti-Mouse CD8a-UNLB
-
纯化方法
- Purified
-
免疫原
- Spleen cells or thymocyte membranes
-
亚型
- IgG2a
-
-
-
-
应用备注
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , Depletion - Reported in literature , Block - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 2 g/106 cells FITC and BIOT conjugates 2 g/106 cells AF488 conjugate 1 g/106 cells PE, APC, SPRD, PE/TXRD, CY5, PE/CY5.5, PE/CY7, 0.2 g/106 cells APC/CY5.5, APC/CY7, PACBLU, AF647, and AF700 conjugates For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
说明
-
In vivo and in vitro depletion of CD8a+ cells
-
样本量
- 1 mL
-
限制
- 仅限研究用
-
-
-
浓度
- 0.5 mg/mL
-
缓冲液
- 0.5 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
-
储存液
- Without preservative
-
注意事项
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
储存条件
- 4 °C
-
储存方法
- Store at 2-8°C
-
-
-
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines." in: Cancer immunology, immunotherapy : CII, (2012) (PubMed).
: "
-
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines." in: Cancer immunology, immunotherapy : CII, (2012) (PubMed).
-
- CD8 alpha (CD8A) (CD8a Molecule (CD8A))
-
别名
- CD8a
-
背景
- In the mouse, CD8 exists in two forms: (i) a CD8 heterodimer composed of an chain (CD8/Lyt-2) and a chain (CD8/Lyt-3), and (ii) a homodimer of two chains. The heterodimer is found on the surface of essentially all thymocytes and the suppressor/cytotoxic subpopulation of mature T lymphocytes. Subsets of intestinal intraepithelial lymphocytes express CD8 without CD8. It has been suggested that CD8+- T cells mature extrathymically, while development of the CD8++ population of T cells is thymus-dependent. CD8 acts as a coreceptor with MHC Class I-restricted T cell receptors in antigen recognition and positive selection of MHC class I-restricted CD8+ T cells. In vivo and in vitro treatment with the 53-6.7 monoclonal antibody effectively depletes CD8+ cells.
-
途径
- TCR Signaling
抗原
-